Monitor for any subsequent amendments or a potential conversion to a 13D if the fund's intent changes. The stake is just above the 5% threshold, so further accumulation or reduction will trigger additional filings.
STRO drugs
STRO drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $10.61entry
- T+1 · 7d ago −4.15%α −3.78% · $10.17
- T+5 · 20h ago −12.16%α −10.47% · $9.32
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Coastlands Capital LP disclosed a new 5.14% passive stake in Sutro Biopharma, holding 852,669 shares as of November 5, 2026. This is a new 13G filing, not an amendment, indicating a fresh position crossing the 5% threshold. The stake is modest in size and the fund certifies passive intent, making this a routine disclosure with limited immediate price impact.
Key Financial Metrics
Key Facts
- Coastlands Capital LP filed a new Schedule 13G disclosing beneficial ownership of 852,669 shares of Sutro Biopharma common stock.
- The stake represents 5.14% of shares outstanding, based on 16,581,171 shares outstanding as of August 7, 2026.
- The filing certifies passive intent under Rule 13d-1(b) and (c), with no purpose of changing or influencing control.
- The shares are held directly by Coastlands Capital Partners LP; the reporting persons include Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and Matthew D. Perry.
- This is a new position (initial 13G), not an amendment to a prior filing.
Financial Impact
852,669 shares valued at approximately $4.3M based on market cap of $152M and 16.58M shares outstanding.
Risk Factors
- Passive 13G status could change if the fund later engages with management or seeks board representation, requiring a 13D filing.
- No indication of activist intent; the filing is routine and unlikely to drive near-term stock movement.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-124373 |
| Document: 0001104659-26-124373-index-headers.html | 0001104659-26-124373 |
| Document: 0001104659-26-124373-index.html | 0001104659-26-124373 |
| Document: 0001104659-26-124373.txt | 0001104659-26-124373 |
Track record
8 reports on STRO
2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +50.74% at T+20 after the Mar 23, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Bearish 5/10 Entry $9.82 to $9.32 Now $9.32 +5.09% ▲ +5.09% +3.18% vs SPY
- Nov 9, 20267d ago SC 13G Neutral 3/10 Viewing Entry $10.61 to $10.17 Now $9.32 −12.16% ▼ −4.15% −3.78% vs SPY
- Aug 12, 202613w ago 8-K Bullish 7/10 No price data
- Aug 12, 202613w ago Press Release Mixed 6/10 Entry $21.30 to $21.31 Now $9.32 −56.24% ▲ +0.05% −0.65% vs SPY
- Apr 22, 202629w ago DEFA14A Neutral 3/10 Entry $34.83 to $33.33 Now $9.32 −73.24% ▼ −4.31% −5.09% vs SPY
- Apr 19, 202630w ago Press Release Bullish 7/10 Entry $34.58 to $34.35 Now $9.32 −73.05% ▼ −0.67% −0.01% vs SPY
- Mar 23, 202634w ago S-3 Bearish 6/10 Entry $23.57 to $23.50 Now $9.32 +60.46% ▲ +0.30% +0.86% vs SPY
- Mar 23, 202634w ago Press Release Bullish 7/10 Entry $23.57 to $23.50 Now $9.32 −60.46% ▼ −0.30% −0.86% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers